eryaspase: Clinical Trials

3 trials of eryaspase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 31Terminated 1

Follow eryaspase: new trials by email Literature Review of eryaspase trials Research Report on eryaspase

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
eryaspase (L-asparaginase encapsulated in red blood cells), Gemcitabine, Carboplatin - Triple Negative Breast Cancer
Phase 2 / Phase 3TerminatedERYtech Pharma272019-06-132022-08-01
Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase
GRASPA - Acute Lymphoblastic Leukemia
Phase 2CompletedBirgitte Klug Albertsen552017-08-232024-03-15
GRASPA Treatment for Patients With Acute Myeloblastic Leukemia
GRASPA - Acute Myeloid Leukemia
Phase 2CompletedERYtech Pharma1232013-02-012022-02-21

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

ERYtech Pharma (2)  ·  Birgitte Klug Albertsen (1)

Countries

Belgium (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Hungary (1)  ·  Lithuania (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Brigitte Klug Albertsen, MD, PhD (1)  ·  X Thomas, Doctor (1)

NIH funding

2016 (1)